When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

HIV-related opportunistic infections

Última revisão: 2 Dec 2025
Última atualização: 11 Sep 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • no antiretroviral treatment (ART) or failure of ART
  • fever
  • headache and altered mental status
  • dyspnea or cough
  • abdominal pain, diarrhea, weight loss
  • dysphagia
  • lymphadenopathy
  • visual floaters, eye pain, and blindness
  • ocular hemorrhage
  • mucosal changes
Detalhes completos

Outros fatores diagnósticos

  • hepatosplenomegaly
  • exercise-induced oxygen desaturation
  • blurred vision and photophobia
  • papilledema
  • meningismus, focal neurologic findings
  • pain and weakness
  • bone or joint pain
  • skin lesions
Detalhes completos

Fatores de risco

  • post-HIV seroconversion with any CD4 count
  • CD4 count below 250 cells/microliter
  • CD4 count below 200 cells/microliter
  • CD4 count below 150 cells/microliter
  • CD4 count below 100 cells/microliter
  • CD4 count below 50 cells/microliter
  • no antiretroviral treatment (ART) or failure of ART
  • men who have sex with men (MSM)
  • black or Hispanic race
  • intravenous drug use
  • socioeconomic factors (poverty, overcrowding, homelessness, poor nutrition)
  • dust inhalation in areas endemic for Coccidioides and Histoplasma
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • CD4 cell count
  • sputum stain and culture
  • blood cultures
  • adenosine deaminase
  • Toxoplasma gondii serology
  • Coccidioides serology
  • cryptococcal polysaccharide antigen
  • Histoplasma capsulatum antigen
  • Histoplasma capsulatum culture
  • CBC
  • LFT
  • LDH
  • ABG
  • CXR
  • head CT
Detalhes completos

Tests to avoid

  • cytomegalovirus (CMV) serology
  • quantitative cytomegalovirus (CMV) polymerase chain reaction (PCR)
Detalhes completos

Investigações a serem consideradas

  • tuberculosis (TB) nucleic acid amplification
  • lateral flow urine lipoarabinomannan (LF-LAM) assay
  • bronchoalveolar lavage (BAL)
  • oropharyngeal scrapings (KOH prep) and culture
  • cerebrospinal fluid (CSF) analysis
  • polymerase chain reaction (PCR): cerebrospinal fluid (CSF), bronchoalveolar lavage (BAL) fluid, and vitreous and aqueous humor specimen for Toxoplasma gondii
  • bone marrow aspirate and culture
  • lymph node aspirate or biopsy
  • tissue biopsy
  • brain biopsy
  • abdominal CT
  • high-resolution CT (HRCT) of the chest
  • polymerase chain reaction (PCR) for Pneumocystis jirovecii pneumonia (PCP)
  • beta-D-glucan
  • brain MRI
  • thallium single photon emission tomography and PET
  • upper gastrointestinal endoscopy and colonoscopy
  • coccidioidal antigen testing
  • polymerase chain reaction (PCR) for Coccidioides
  • polymerase chain reaction (PCR) for Histoplasma
Detalhes completos

Algoritmo de tratamento

AGUDA

Mycobacterium tuberculosis infection

disseminated M avium complex

Pneumocystis jirovecii pneumonia

Toxoplasma gondii infection encephalitis

cryptococcal meningitis

cytomegalovirus

mucocutaneous candidiasis

coccidioidomycosis

disseminated histoplasmosis

Colaboradores

Autores

Jake Scott, MD

Clinical Associate Professor

Infectious Diseases and Geographic Medicine

Stanford University School of Medicine

Antimicrobial Stewardship Program Medical Director

Stanford Health Care Tri-Valley

Pleasanton

CA

Declarações

JS declares that he has no competing interests.

Agradecimentos

Dr Jake Scott would like to gratefully acknowledge Dr, Ruth Byrne, Dr Mark Nelson, and Dr Irene Alexandraki, previous contributors to this topic.

Declarações

RB, MN, and IA declare that they have no competing interests.

Revisores

Thomas B. Campbell, MD

Professor of Medicine

University of Colorado Anschutz

Aurora

CO

Declarações

Unpaid member of the US DHHS Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV and the National Comprehensive Cancer Network Guidelines for Cancer in People with HIV and Kaposi Sarcoma.

Ellen Kitchell, MD, FIDSA, AAHIVM-S

Associate Professor

University of Texas Southwestern

Dallas

TX

Declarações

EK declares that she has no competing interests.

Colm O'Mahony, MD, FRCP, BSc, DIPVen

Consultant in Sexual Health

Department of Sexual Health

Countess of Chester Hospital NHS Foundation Trust

Chester

UK

Declarações

CO declares that he has no competing interests.

Nicola Steedman, MRCP, DipGUM, DipHIV

Consultant Physician in Sexual Health and HIV

Department of Sexual Health

Countess of Chester Hospital NHS Foundation Trust

Chester

UK

Declarações

NS declares that she has no competing interests.

William R. Rodriguez, MD

Assistant Professor of Medicine

Massachusetts General Hospital

Charlestown

MA

Declarações

WRR declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. 2025 [internet publication].Texto completo

World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Jun 2022 [internet publication].Texto completo

Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416.Texto completo  Resumo

Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007 Oct 1;45(7):807-25.Texto completo  Resumo

Chang CC, Harrison TS, Bicanic TA, et al. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024 Aug;24(8):e495-512.Texto completo  Resumo

Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1-50.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Diagnósticos diferenciais

    • Pneumonia
    • Diarrhea
    • Meningitis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
    • Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society–USA panel
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Tuberculosis

    Toxoplasmosis in pregnancy: what is it?

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal